Skip to content

Clinical translational research on a new myocardial perfusion imaging tracer and relative quantification technique

Clinical translational research on a new myocardial perfusion imaging tracer and relative quantification technique

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094261
Enrollment
Unknown
Registered
2024-12-19
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

Gold Standard:The second part: Myocardial blood flow values by 13N-NH3 PET/CT. The third part: Hemodynamically obstructive CAD was defined as high-grade stenosis (>90% diameter stenosis) by visual ass
Index test:rest myocardial blood flow, stress myocardial blood flow, myocardial blood flow reserve

Sponsors

Chinese Academy of Medical Sciences & Fuwai Hospital, National Center for Cardiovascular Diseases
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: This project consists of four parts. The first part will use retrospective data and does not involve inclusion criteria. The second part: Patients with known or suspected CAD who are scheduled for clinically indicated SPECT myocardial perfusion imaging. The third part: 1. Angina symptoms such as chest tightness and pain; 2. At least one coronary stenosis =50% in CTA. The forth part: Patients with known or suspected CAD who are scheduled for clinically indicated SPECT myocardial perfusion imaging

Exclusion criteria

Exclusion criteria: This project consists of four parts. The first part will use retrospective data and does not involve exclusion criteria. The second part: 1. Contraindication for adenosine stress test; 2. Pregnant or breastfeeding; 3. Not agree to sign consent form. The third part: 1. prior revascularization including coronary artery bypass grafting and percutaneous coronary intervention within 6 months; 2. Nonischemic cardiomyopathy or LVEF<35%; 3. Contraindication for adenosine stress test; 4. Pregnant or breastfeeding; 5. Not agree to sign consent form. The forth part: 1. Contraindication for adenosine stress test; 2. Pregnant or breastfeeding; 3. Not agree to sign consent form.

Design outcomes

Primary

MeasureTime frame
myocardial blood flow;myocardial flow reserve;coronary stenosis;fractional flow reserve;Accuracy;Sensitivity;Specificity;

Secondary

MeasureTime frame
Positive predicative value;Negative predictive value;

Countries

China

Contacts

Public ContactLei Wang

Chinese Academy of Medical Sciences & Fuwai Hospital, National Center for Cardiovascular Diseases

leiwangfw@126.com+86 152 0150 6408

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026